In accordance to the in vitro results RT-qPCR did not demonstrate any increase in HLA-A and β2m mRNA expression in response to treatment with V plus MA, supporting the assumption that HDAC inhibitor mediated HLA class-I induction on MCC cells is largely mediated by an enhanced antigen processing (Fig. 4A). The gene discussed is HLA-A; the disease is Merkel cell skin cancer.